EUCTR2006-005235-14-CZActive, not recruitingNot Applicable
A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users - INDUCTIO
Schering-Plough Research Institute - A division of Schering-Plough Corp.0 sites310 target enrollmentStarted: June 11, 2007Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 310
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Subjects must be males or non-pregnant, non-lactating females.
- •2. Subjects must be at least 15 years of age, of either sex, and any race.
- •3. Subjects (and/or the parent or guardian for subjects under the age of legal consent or who otherwise are unable to provide independent consent) must demonstrate willingness to participate in the study and to adhere to dose and visit schedules.
- •4. Subjects must meet Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria(24) for opioid dependence.
- •5. Subjects must have a methadone- and buprenorphine-negative UDS result
- •prior to randomization.
- •6. Each subject must confirm that he or she is practicing adequate contraception. Female volunteers of childbearing potential (including women who are less than 1 year postmenopausal and women who will be sexually active during the study) must agree to use a medically accepted method of contraception or must be surgically sterilized prior to screening, while receiving protocol-specified medication, and for 30 days after stopping the medication. Women who have been postmenopausal for =1 year (ie, women who have experienced 12 or more consecutive months of amenorrhea) will be exempted from the requirement to use contraception during the study. Acceptable methods include hormonal implants, injectables, combined oral contraceptives, hormonal intrauterine devices and surgical sterilization (eg, hysterectomy or tubal ligation).
- •7. Female subjects of childbearing potential must have a negative urine beta–
- •human chorionic gonadotropin (beta-hCG) test prior to enrollment in the study.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •1. Subjects for whom treatment with either Subutex or Suboxone as required in
- •the protocol would be inconsistent with national labeling.
- •2. Subjects who are unwilling or unable to comply with the requirements of the protocol (eg, pending incarceration) or are in a situation or condition that, in the opinion of the investigator, may interfere with participation in the study.
- •3. Subjects who are participating in any other clinical study in which medication(s) are being delivered.
- •4. Subjects with known allergy or sensitivity to buprenorphine or naloxone.
- •5. Subjects who are on the staff, affiliated with, or a family member of the staff
- •personnel directly involved with this study.
- •6. Subjects with serious untreated Axis I DSM-IV-TR psychiatric co-morbidity (eg, those who are actively suicidal or homicidal, have untreated schizophrenia, etc). Polysubstance abuse or dependence will not exclude subjects except in the case of unauthorized and significant benzodiazepine use requiring medical detoxification or alcohol dependence requiring medical detoxification.
- •7. HIV-positive subjects with clinical acquired immunodeficiency syndrome (AIDS).
- •8. Methadone or buprenorphine maintenance or detoxification within 30 days of enrollment.
Investigators
Similar Trials
Active, not recruiting
Phase 1
A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin UsersOpioid dependenceMedDRA version: 9.1 Level: LLT Classification code 10013663 Term: Drug dependenceEUCTR2006-005235-14-FRIntegrated Therapeutics Group Inc
Active, not recruiting
Not Applicable
A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users - INDUCTIOEUCTR2006-005235-14-PTSchering-Plough Research Institute - A division of Schering-Plough Corp.310
Active, not recruiting
Not Applicable
A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users - INDUCTIOOpioid dependenceMedDRA version: 9.1Level: LLTClassification code 10013663Term: Drug dependenceEUCTR2006-005235-14-SISchering-Plough Research Institute - A division of Schering-Plough Corp.310
Active, not recruiting
Phase 1
A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users - INDUCTIOEUCTR2006-005235-14-GBSchering-Plough Research Institute - A division of Schering-Plough Corp.
Active, not recruiting
Phase 1
A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users - INDUCTIOOpioid dependenceMedDRA version: 9.1Level: LLTClassification code 10013663Term: Drug dependenceEUCTR2006-005235-14-DESchering-Plough Research Institute - A division of Schering-Plough Corp.